| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 81513 |
|
68 |
68 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
141 |
135 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
44 |
42 |
$4K |
| 76830 |
Ultrasound, transvaginal |
39 |
39 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
117 |
116 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
117 |
116 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
114 |
114 |
$3K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
126 |
124 |
$3K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
19 |
18 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
66 |
65 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
35 |
31 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
26 |
26 |
$2K |
| 0012A |
|
35 |
35 |
$1K |
| 0011A |
|
34 |
34 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
25 |
24 |
$1K |
| 76820 |
|
22 |
20 |
$1K |
| 81025 |
|
237 |
224 |
$726.90 |
| 87481 |
|
14 |
14 |
$392.98 |
| 81002 |
|
248 |
235 |
$282.13 |
| 36415 |
Collection of venous blood by venipuncture |
91 |
83 |
$41.47 |
| 99000 |
|
32 |
31 |
$2.26 |